Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Recker

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 3, 2004
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosisCharles H Chesnut, Arne Skag, Claus Christiansen, et al.
Journal of Proteome Research|May 24, 2012
Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 miceDanjun Ma, Yan Li, Bryan Hackfort, et al.
Current Medical Research and Opinion|September 14, 2006
Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trialRobert Recker, Paul Lips, Dieter Felsenberg, et al.
Experimental Hematology & Oncology|July 30, 2013
Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cellsJiarui Wang, Xuemei Zhang, Danjun Ma, et al.
Plos One|November 15, 2014
Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian womenQiu-Hong Zhou, Lan-Juan Zhao, Ping Wang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 3, 2020
Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its ExtensionRobert Recker, David Dempster, Bente Langdahl, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2013
Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trialKim Brixen, Roland Chapurlat, Angela M Cheung, et al.
Calcified Tissue International|November 15, 2012
A novel monthly dosing regimen of risedronate for the treatment of postmenopausal osteoporosis: 2-year dataMichael R McClung, Claude-Laurent Benhamou, Zulema Man, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 27, 2015
Aging Versus Postmenopausal Osteoporosis: Bone Composition and Maturation Kinetics at Actively-Forming Trabecular Surfaces of Female Subjects Aged 1 to 84 YearsEleftherios P Paschalis, Peter Fratzl, Sonja Gamsjaeger, et al.
Journal of Proteome Research|December 29, 2009
Inhibition of protein phosphorylation in MIA pancreatic cancer cells: confluence of metabolic and signaling pathwaysHengwei Zhang, Rui Cao, Wai-Nang Paul Lee, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 3, 2004
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosisCharles H Chesnut, Arne Skag, Claus Christiansen, et al.
Journal of Proteome Research|May 24, 2012
Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 miceDanjun Ma, Yan Li, Bryan Hackfort, et al.
Current Medical Research and Opinion|September 14, 2006
Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trialRobert Recker, Paul Lips, Dieter Felsenberg, et al.
Experimental Hematology & Oncology|July 30, 2013
Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cellsJiarui Wang, Xuemei Zhang, Danjun Ma, et al.
Plos One|November 15, 2014
Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian womenQiu-Hong Zhou, Lan-Juan Zhao, Ping Wang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 3, 2020
Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its ExtensionRobert Recker, David Dempster, Bente Langdahl, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2013
Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trialKim Brixen, Roland Chapurlat, Angela M Cheung, et al.
Calcified Tissue International|November 15, 2012
A novel monthly dosing regimen of risedronate for the treatment of postmenopausal osteoporosis: 2-year dataMichael R McClung, Claude-Laurent Benhamou, Zulema Man, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 27, 2015
Aging Versus Postmenopausal Osteoporosis: Bone Composition and Maturation Kinetics at Actively-Forming Trabecular Surfaces of Female Subjects Aged 1 to 84 YearsEleftherios P Paschalis, Peter Fratzl, Sonja Gamsjaeger, et al.
Journal of Proteome Research|December 29, 2009
Inhibition of protein phosphorylation in MIA pancreatic cancer cells: confluence of metabolic and signaling pathwaysHengwei Zhang, Rui Cao, Wai-Nang Paul Lee, et al.
Pageof 4